Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 21 Sep 2019
ABSCH-IRCC-IN-247838-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/1808
Application in Form-III for seeking approval for the invention on "Anti-arthritic and anti-paralytic herbal oil formulation and process for the preparation thereof" for obtaining IP Rights in India
Indian Patent Application Number: 201611033966
Indian Patent Application Number: 201611033966
25 Sep 2018
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Person:Mr Mohan LalVillage Kuddi, Taluk Chowari, Dist ChambaChamba, Himachal Pradesh
176313, IndiaPhone: +917807053489,Fax:Email: mhnlal29@gmail.com,Website:
Person:Mr Tarun KhuranaAttorney of the applicant, M/s. Khurana & Khurana, Advocates and IP Attorneys,E-13, UPSIDC, Site-IV, Behind-Grand Venice, Kasna Road, National Capital Region,Greater Noida, Uttar Pradesh
201310,Phone: +91 9810617992,Fax:Email: info@khuranaandkhurana.com,Website:
Confidential information
Yes
1. The user shall notify NBA within 60 days from the date of grant of IPR.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes.
3. The user shall inform NBA about any commercialization made on the IP Rights granted.
4. The user shall submit annual report to NBA as per the terms and conditions agreed upon.
Confidential information
Confidential information
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument, which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-247838-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
21 Sep 2019 13:50 on 21 Sep 2019 13:50
|
